Mesh Technology Taiwan provides Video as a Service and Infrastructure as a Service for private/public 5G networks. We combined 5G FWA and MEC to enable 5G applications on edge. Our 5G Distributed Edge Network supports trillions of connections from Smart City, Smart devices, and Smart Applications to Autonomous vehicles.

Our current clients cover Telehealth, Esports, Telcos (Smart Pole), etc.

Highlight 2021: Top 30 Taiwan Startups by BNext Media
Highlight 2022: Qualcomm 5G Innovative Taiwan Competition 1 of 10 finalists out of 200+ teams

MUI Robotics is the provider of Artificial Sense platform (Sensor, AI and IoT technologies).
Our Electronic Nose (MUI Nose) is a tool for odors monitoring and analyzation. Our device mimics human olfaction
and turns it into data for consistent quality control, product development or environmental & safety control without
human error.

More Foods Innotech is a leading plant-based food start-up in Thailand under product line, namely “More Meat”. With the consumer’s increasing awareness of food ingredients, as well as growing interest in natural, eco-friendly and sustainable food sources, we offer products made with quality ingredients, highlighting on nutrition, using local plants of Thailand that have bioactive compounds to promote good health, as well as sourcing from smaller producer groups to create sustainable income and job opportunities for the community.
Since its establishment in 2019, we have partnered with large food companies like V Foods Thailand and Thai Union to scale up and create impacts for the people.

– Problem:
The largest problem of global comic distribution is the slow speed / high cost of translation. These problems prevent publishers from delivering their comics abroad.
Consequently, manga (Japanese comics) are currently mostly served by low-quality, unprofessional, pirated translations on sleezy sites. The pirated Manga market in the US is estimated to be $10B/year, which is hugely damaging to publishers and Manga authors.

– Product:
We are building a comic translation tool for publishers to create an appropriate pipeline that connects comic artists and readers beyond language barriers. It contains i) a machine translation engine designed for comcis and ii) a post-editing tool for translators/letters. The translation engine achieves the best accuracy in the world (Compared with Google Translate, our engine performs similar to human translation by 3.6 points BLEU [Papineni+2002]). Combined with our online post-editing tool, the translation system accelerate the speed of comic translation by 2x.

– Business model & Tractions
We charge $1000-$5000 per month for our comic translation tool.
Within a month of the launch, 20+ publishers and online comic distributors had requested a free trial, and one of them had already switched to a paid plan ($1000/month).

Meracle brings relief and assurance to patients with respiratory and chronic ailments by optimizing the delivery of therapy in a safe, reliable and efficient manner, with the ultimate goal of setting the industry’s benchmarks and standards. Meracle’s first product, the Whizz, improves the management of respiratory conditions by increasing the efficiency of medication delivered into the lungs while tracking intake data to augment the assessment of treatment outcomes. Through trials we have shown that the Whizz improves technique and compliance by 100%, leading to better asthma control and reduced symptoms. The system consist of a hardware that helps deliver medication effectively to patients, paired to a mobile application that has multiple features to track and encourage compliance through gamification as well as manage treatment regimen. The data collected benefits multiple stakeholders, by first improving the quality of life of patients and helping them gain a sense of control over their situation. Doctors have access to objective data that makes it easier to target accurate prescription medication and governments are able to improve public health and reduce the burden on an overwhelmed healthcare system.

Microblue IntelligenceはAI可視化技術を業界全体で提供するテックカンパニーである。弊社はビジュアルプロジェクトを素早く実装する能力を有する専門集団であり、プロジェクトの状況に応じて複数の展開プラン（ローカルやクラウドでの展開を含む）を用意している。
業界内で主流となっているAIアルゴリズムを活用しコア技術を熟知している（ターゲット認識、欠陥検出、ビジュアル分類など）。顧客の実際の応用に関する文脈を評価し、素早く正確にカスタム化したサービスを提供できる。

Metcela Inc. は日本発の前臨床段階のバイオテック系スタートアップである。Metcelaでは、「VCF」あるいはVCAM-1-positive cardiac fibroblastと呼ばれる心臓特有の線維芽細胞を使った、革新的かつ臨床的に実行可能で有効な慢性心不全の細胞治療法を開発している。心臓機能におけるVCFの影響は動物を使った様々な心不全モデルによって実証されている。VCFの主な機能は梗塞している心臓の微細環境を修正し既存の心細胞の生存と増殖を促すことである。他の多くの技術とは異なり、弊社のアプローチは既に心臓にある細胞を単純かつ真に再生させVCFが創り出すより生息しやすい環境で繁栄させるというものである。
細胞を届けるために日本における大手カテーテルメーカーと提携し独特の注入カテーテルシステムを開発し、臨床医による梗塞した領域へのVCFの精密な注入を支援できるようにした。VCF固有の特徴と最先端の精密送達カテーテル技術を組み合わせることにより、2021年初頭に医師主導型の第I相臨床試験を開始し、後に世界各地に本技術を提供するといった準備を進めている。

Motoricaはロシアを本拠地とし、中国やインドにも事務所を設け医療やロボティクスの研究開発に集中している。設立以来、弊社は義手システムや補助技術によるリハビリテーションの開発に取り組んでいる。チームの半分はR&D職員や医療専門家である。
Motoricaは義肢ケアにおける古い考え方に疑問を投げかけている。チームは義肢にユーザーと疎通し、インターネットにアクセスし、音声コマンドを実施し、決済を行うといった行為を教え込んでいる。2018年にはMotoricaはバーチャルリアリティーに基づいたリハビリテーションプラットフォームや、義肢デバイスのgsm-モジュールを通じたテレメトリーデータ収集プラットフォームの開発を開始した。現在はサイバーテクノロジー市場の主なユーザーは障碍者であり、弱みを強みへと変えている。